These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34761594)

  • 21. EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties.
    Li Y; Chu J; Feng W; Yang M; Zhang Y; Zhang Y; Qin Y; Xu J; Li J; Vasilatos SN; Fu Z; Huang Y; Yin Y
    FASEB J; 2019 Apr; 33(4):4851-4865. PubMed ID: 30620624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDK1 promotes the stemness of lung cancer cells through interacting with Sox2.
    Huang Z; Shen G; Gao J
    Clin Transl Oncol; 2021 Sep; 23(9):1743-1751. PubMed ID: 33721187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2/SMO/GLI1 network loop.
    Chen WW; Gong KK; Yang LJ; Dai JJ; Zhang Q; Wang F; Li XL; Xi SC; Du J
    J Ethnopharmacol; 2021 Jan; 265():113295. PubMed ID: 32841701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway.
    Srinual S; Chanvorachote P; Pongrakhananon V
    Int J Oncol; 2017 Apr; 50(4):1341-1351. PubMed ID: 28259926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractionated Irradiation Enhances Invasion and Migration by Inducing Epithelial-Mesenchymal Transition and Stemness-Like Properties in A549 Cells.
    Liu L; Shang M; Song X; Zhang C; Guo W
    Ann Clin Lab Sci; 2021 Jul; 51(4):521-528. PubMed ID: 34452890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of aqueous extracts of gecko on stemness of hepatocellular carcinoma].
    Huang HL; Zhang YL; Chen WF; Wu CL
    Zhongguo Zhong Yao Za Zhi; 2017 Oct; 42(20):3990-3995. PubMed ID: 29243438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/β-catenin pathway.
    Su K; Huang L; Li W; Yan X; Li X; Zhang Z; Jin F; Lei J; Ba G; Liu B; Wang X; Wang Y
    J Surg Res; 2013 Nov; 185(1):255-63. PubMed ID: 23880650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
    Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
    PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 33. Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4.
    Phiboonchaiyanan PP; Chanvorachote P
    Cell Oncol (Dordr); 2017 Oct; 40(5):497-510. PubMed ID: 28677037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt/β-catenin signaling pathway in lung cancer stem cells is a potential target for the development of novel anticancer drugs.
    Jiang HL; Jiang LM; Han WD
    J BUON; 2015; 20(4):1094-100. PubMed ID: 26416062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting transient receptor potential canonical 1 reduces non‑small cell lung cancer chemoresistance and stemness via inhibition of PI3K/AKT signaling.
    Jin J; Yan X; Zhao Y; Zhang H; Zhuang K; Wen Y; He J; Gao J
    Oncol Lett; 2023 Jun; 25(6):224. PubMed ID: 37153044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rab37 mediates exocytosis of secreted frizzled-related protein 1 to inhibit Wnt signaling and thus suppress lung cancer stemness.
    Cho SH; Kuo IY; Lu PF; Tzeng HT; Lai WW; Su WC; Wang YC
    Cell Death Dis; 2018 Aug; 9(9):868. PubMed ID: 30158579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trefoil factor 3 silencing can inhibit the proliferation and apoptosis of lung cancer cells.
    Liu M; Xiao Y
    J BUON; 2021; 26(5):1842-1849. PubMed ID: 34761591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway.
    Guo YZ; Xie XL; Fu J; Xing GL
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4898-4907. PubMed ID: 30070325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.